Literature DB >> 15566885

Virus-induced interferon production in leukocyte cultures from children with recurrent respiratory infections. A follow-up study.

A Pitkäranta1, P Karma, T Hovi.   

Abstract

BACKGROUND: Lowered yields of virus-induced interferon (IFN) by leukocyte cultures were previously suggested to be associated with recurrent respiratory infections in children (Pitkaranta et al. (1993) Clin. Diagn. Virol. 1, 101-108).
OBJECTIVES: To investigate if the observed lowered IFN producing capacity was secondary to the underlying disease and, consequently, would be normalized after recovery of the child from the chain of infections. STUDY
DESIGN: Forty-eight 3-12-year-old children suffering from recurrent upper respiratory tract infections (acute otitis media included) were followed-up for 2 years. Their clinical condition and virus-induced interferon production in cultures of peripheral blood leukocytes were examined at the beginning and end of this period.
RESULTS: In 24 children the health improved strikingly during the follow-up, in 12 children a mild improvement took place, while 12 children remained constantly ill. IFN yields in cultures stimulated with corona- and respiratory syncytial viruses improved along with the clinical situation of the children. Parallel cultures induced with adeno-, influenza A or rhinoviruses did not show a similar correlation.
CONCLUSION: These results suggest that the relationship between interferon production by leukocyte cultures and recurrent infections is complex and may be virus-specific.

Entities:  

Year:  1996        PMID: 15566885      PMCID: PMC7134928          DOI: 10.1016/0928-0197(96)00207-3

Source DB:  PubMed          Journal:  Clin Diagn Virol        ISSN: 0928-0197


  17 in total

1.  Infections and other illnesses of children in day-care centers in Helsinki. I: Incidences and effects of home and day-care center variables.

Authors:  A Pönkä; T Nurmi; E Salminen; E Nykyri
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

2.  Interferon production in patients infected with HIV-1.

Authors:  S Rossol; R Voth; H P Laubenstein; W E Müller; H C Schröder; K H Meyer zum Büschenfelde; G Hess
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

3.  Interferon response of human leukocytes during intrauterine and postnatal life.

Authors:  K Cantell; H Strander; L Saxén; B Meyer
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

4.  Frequency and severity of infections in day care.

Authors:  E R Wald; B Dashefsky; C Byers; N Guerra; F Taylor
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

Review 5.  Middle ear problems in childhood.

Authors:  K Prellner; O Kalm; G Harsten
Journal:  Acta Otolaryngol Suppl       Date:  1992

6.  Virus-induced interferon production in human leukocytes: a low responder to one virus can be a high responder to another virus.

Authors:  A Pitkäranta; K Linnavuori; T Hovi
Journal:  J Interferon Res       Date:  1991-02

7.  Age-related decline of human interferon alpha and interferon gamma production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Blut       Date:  1984-05

Review 8.  Current issues in upper respiratory tract infections in infants and children: rationale for antibacterial therapy.

Authors:  J O Klein
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

9.  Interferon production in children with respiratory diseases.

Authors:  K Vanĕcek; A Lehovcová
Journal:  Acta Paediatr Scand       Date:  1985-01

10.  Deficiency in interferon production by leukocytes from children with recurrent respiratory infections.

Authors:  A Pitkäranta; P Karma; T Hovi
Journal:  Clin Diagn Virol       Date:  1993-07
View more
  1 in total

1.  Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children.

Authors:  A Pitkäranta; J Nokso-Koivisto; V Jäntti; A Takala; T Kilpi; T Hovi
Journal:  J Clin Virol       Date:  1999-12       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.